<bill session="109" type="s" number="3822" updated="2013-07-19T20:46:42-04:00">
  <state datetime="2006-08-03">REFERRED</state>
  <status>
    <introduced datetime="2006-08-03"/>
  </status>
  <introduced datetime="2006-08-03"/>
  <titles>
    <title as="introduced" type="short">Genomics and Personalized Medicine Act of 2006</title>
    <title as="introduced" type="official">A bill to improve access to and appropriate utilization of valid, reliable and accurate molecular genetic tests by all populations thus helping to secure the promise of personalized medicine for all Americans.</title>
  </titles>
  <sponsor id="400629"/>
  <cosponsors/>
  <actions>
    <action datetime="2006-08-03">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S8840-8841"/>
    </action>
    <action state="REFERRED" datetime="2006-08-03">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Accreditation (Medical care)"/>
    <term name="Citizen participation"/>
    <term name="Civil rights and liberties, minority issues"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Continuing education"/>
    <term name="Cost effectiveness"/>
    <term name="Curricula"/>
    <term name="Data banks"/>
    <term name="Deceptive advertising"/>
    <term name="Department of Health and Human Services"/>
    <term name="Discrimination in medical care"/>
    <term name="Distance education"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug utilization"/>
    <term name="Economics and public finance"/>
    <term name="Education"/>
    <term name="Environmental health"/>
    <term name="Environmental protection"/>
    <term name="Epidemiology"/>
    <term name="Ethnic groups"/>
    <term name="Executive reorganization"/>
    <term name="Federal aid to education"/>
    <term name="Federal aid to health facilities"/>
    <term name="Finance and financial sector"/>
    <term name="Gene therapy"/>
    <term name="Genetic counseling"/>
    <term name="Genetic research"/>
    <term name="Genetics"/>
    <term name="Government operations and politics"/>
    <term name="Governmental investigations"/>
    <term name="Health information systems"/>
    <term name="Health surveys"/>
    <term name="Health warnings"/>
    <term name="Hereditary diseases"/>
    <term name="Higher education"/>
    <term name="Income tax"/>
    <term name="Labeling"/>
    <term name="Labor and employment"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Marketing"/>
    <term name="Medical economics"/>
    <term name="Medical education"/>
    <term name="Medical laboratories"/>
    <term name="Medical personnel"/>
    <term name="Medical records"/>
    <term name="Medical research"/>
    <term name="Medical residents"/>
    <term name="Medical statistics"/>
    <term name="Medical tests"/>
    <term name="Minorities"/>
    <term name="Minorities in medicine"/>
    <term name="Minority health"/>
    <term name="Mortality"/>
    <term name="Pharmaceutical research"/>
    <term name="Quality of care"/>
    <term name="Quality of life"/>
    <term name="Races"/>
    <term name="Recruiting of employees"/>
    <term name="Research and development"/>
    <term name="Right of privacy"/>
    <term name="Scholarships"/>
    <term name="Science, technology, communications"/>
    <term name="Standards"/>
    <term name="Tax credits"/>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary>8/3/2006--Introduced.
Genomics and Personalized Medicine Act of 2006 - Requires the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group to expand and accelerate genetics and genomics research and translate such research into clinical and public health applications; (2) expand and accelerate research and programs to collect genetic and genomic data that will advance the field of genomics and personalized medicine; (3) develop a plan for a national biobanking research initiative; (4) expand efforts to increase knowledge about the interaction between genetics and the environment and about ways in which molecular genetic screening, diagnostics, and treatments may be used to improve the health and health care of racial and ethnic minority populations; (5) increase recruitment and retention of trainees in genetics and genomics; (6) ensure the adequacy of genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (7) improve the safety, efficacy, and availability of information about genetic tests; and (8) improve the oversight and regulation of genetic tests. Provides for the recruitment of health professionals from diverse backgrounds in the genomics workforce and improvement in the quality of genomics training. Amends the Internal Revenue Code to establish a tax credit for qualified research expenses for the development of a qualified companion diagnostic test designed to provide information to increase the safety or effectiveness of a drug. Provides for the expansion of adverse event reporting systems to encompass reports of adverse events resulting from genetic testing.</summary>
</bill>
